Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Ucla Division of Hematology-Oncology
Los Angeles, California, United States
- Stanford Hospitals and Clinics
Stanford, California, United States
- Winship Cancer Institute
Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- the Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institiute
Buffalo, New York, United States
- New York Medical College
Hawthorne, New York, United States
- Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt U Medical Center
Nashville, Tennessee, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2007
- Primary completion
- 1 Dec 2018
- Completion
- 1 Dec 2018
- Last update posted
- 4 Jun 2024
- Registered enrollment
- 105
- Registry id
- NCT00590187
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.